3 Biotech Stocks That Soared This Week: Are They Buys?
There's nothing like good results from a clinical study to light a fire beneath a biotech stock. That's what has happened with several biotechs over the last few days.
Madrigal Pharmaceuticals (NASDAQ: MDGL), Spectrum Pharmaceuticals (NASDAQ: SPPI), and Zogenix (NASDAQ: ZGNX) reaped the rewards from recent announcements of clinical results for their respective products, with all three biotech stocks soaring this week. Here are the catalysts driving each stock higher -- and more important, a look at whether or not the biotech stocks are smart picks for investors.
Image source: Getty Images.
Source: Fool.com
Spectrum Pharmaceuticals Aktie
0,95 €
-4,19 %
Derzeit ist die Community gegenüber der Spectrum Pharmaceuticals Aktie mit 0 Sell-Einschätzungen und 1 Buy-Einschätzungen noch unentschlossen.
Das Kursziel von 1 € für Spectrum Pharmaceuticals weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 0.95 € hin.
